Nov. 26, 2012
/PRNewswire/ -- Rochester Medical Corporation (NASDAQ:ROCM) today announced its upcoming participation in The Benchmark Company, LLC Micro Cap Discovery Conference on
Thursday, November 29, 2012
, at the InterContinental Hotel,
David A. Jonas
, Chief Financial Officer, is scheduled to present at
11:20 am Central Time
. The presentation will not be webcast. Mr. Jonas will also host one-on-one meetings with investors.
This press release contains "forward-looking statements" with the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the future financial and operating results of Rochester Medical. Such statements are based on currently available information, operating plans and management's expectations about future events and trends. Such statements inherently involve significant risks and uncertainties that could cause actual results to differ materially from those predicted in such forward-looking statements, including the uncertainty of estimated revenues and profits, the uncertainty of current domestic and international economic conditions that could adversely affect the level of demand for the Company's products and increased volatility in foreign exchange rates, the uncertainty of market acceptance of new product introductions, and our level of success in increasing Rochester Medical Direct Sales revenue, the uncertainty of gaining new strategic relationships or locating and capitalizing on strategic opportunities, the uncertainty of timing of Private Label Sales revenues (particularly international customers), FDA and other regulatory review and response times, and other risk factors listed from time to time in the Company's SEC reports and filings, including, without limitation, the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended
September 30, 2011
, and quarterly reports on Forms 10-Q. Readers are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
About Rochester Medical Corporation
Rochester Medical Corporation develops, manufactures, and markets disposable medical catheters and devices for urological and continence care applications. The Company also sells certain ostomy and wound and scar care products and other brands of urological products into the European marketplace.
For further information, please contact
Anthony J. Conway
, President and Chief Executive Officer or
David A. Jonas
, Chief Financial Officer of Rochester Medical Corporation at (507) 533-9600 or
, CFA, at Westwicke Partners (443) 213-0500. More information about Rochester Medical is available on its website at
SOURCE Rochester Medical Corporation